Skip to content

Supporting women to be active after breast cancer

Feasibility study: EXpanding into communities to imProve physical activity sUpport foR womEn after breast cancer (PURE-EX)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10275223
Enrollment
45
Registered
2026-01-07
Start date
2026-02-02
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant neoplasm of breast Cancer

Interventions

This is a prospective, single-arm, pretest-posttest feasibility trial. The intervention that women will be invited to take part in consists of three main components: [1] An offer of exercise referral
2) Recommending joining a local exercise class as one of the best ways to support recovery
3) Asking whether the woman would like a free referral into a 12-week group exercise class with other women recovering from breast cancer surgery. If the woman agrees to the referral a research nurse,

Sponsors

Newcastle University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Women aged >= 18 years 2. Clinical diagnosis of early-stage locally advanced breast cancer (stage I-III) 3. Have completed surgery for breast cancer 4. Have received clearance from a treating clinician to participate in the study 5. Willing and able to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Diagnosis of metastatic breast cancer (stage IV) 2. Currently undergoing chemotherapy or scheduled to start chemotherapy during the study period 3. Not sufficiently recovered from surgery in a manner that would contraindicate exercise, as determined by the treating clinician (e.g. inadequate wound healing, reduced range of motion, or other clinical concerns) 4. Musculoskeletal, neurological, or rheumatological condition that could be exacerbated by exercise, as determined by the treating clinician 5. Uncontrolled cardiovascular or metabolic disease 6. Pregnant or planning pregnancy during the study period

Countries

England, United Kingdom

Contacts

Public ContactMorven;Sam Brown;Orange

;

morven.brown@newcastle.ac.uk;sam.orange@newcastle.ac.uk+44 0191 282 1344;-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026